27-HC |
27-hydroxycholesterol |
AGR |
anterior gradient |
Akt |
anti-apoptotic kinase |
APC |
adenomatous polyposis coli and |
C3 |
complement C3 |
CA15-3 |
carbohydrate antigen 15-3 |
CA125 |
cancer antigen 125 |
CEA |
carcinoembryonic antigen |
cfDNA |
cell-free DNA |
COMP |
collagen oligomeric matrix protein |
CPXM1
|
carboxypeptidase X |
CRP |
C-reactive protein |
DACH1
|
Dachshund homolog 1 |
DCIS |
ductal carcinomas in situ |
DFS |
disease-free survival |
ECM |
extracellular matrix |
ELISA |
enzyme-linked immunosorbent assay |
EMT |
epithelial-mesenchymal transition |
ER |
estrogen receptor |
EPIC |
European Investigation into Cancer and Nutrition |
FAK |
focal adhesion kinase |
HR |
hormone receptor |
HER2 |
human epidermal growth factor receptor 2 |
HOXA10
|
Homeobox protein Hox-A10 |
iNOS |
inducible nitric oxide synthase |
IDC |
invasive ductal carcinomas |
IHC |
immunohistochemistry |
JAK |
Janus kinase |
KNG1 |
kininogen-1 |
ncRNAs |
non-coding RNAs |
miRNAs or miR |
microRNAs |
mTOR |
mammalian target of rapamycin |
NCOA3 |
nuclear receptor co-activator 3 |
NK cell |
natural killer cell |
ORR |
overall response rate |
OS |
overall survival |
PALOMA3 |
Palbociclib Combined With Fulvestrant in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer After Endocrine Failure |
pCR |
pathologic complete response |
PCR |
polymerase chain reaction |
PD-1 |
programmed cell death protein 1 |
PD-L1 |
programmed death-ligand 1 |
PTEN |
phosphatase and tensin homolog |
PTN |
pleiotrophin |
PI3K |
phosphoinositide-3-kinase |
PFS |
progression-free survival |
PR |
progesterone receptor |
RASGRF1
|
Ras-specific guanine nucleotide-releasing factor 1 |
RAR-β2
|
retinoic acid receptors-β2 |
RFS |
recurrence free survival |
Rb |
retinoblastoma |
SHBG |
sex hormone–binding globulin |
SoFEA |
Study of Faslodex Versus Exemestane With or Without Arimidex |
SOS1 |
SOS Ras/Rac guanine nucleotide exchange factor 1 |
STAT |
signal transducers and activators of transcription |
TAAs |
tumor-associated antigens |
TAMs |
tumor-associated macrophages |
TFF |
trefoil factor |
Th cell |
T helper cell |
TIL |
tumor-infiltrating lymphocytes |
TMB |
tumor mutation burden |
TME |
tumor microenvironment |
TNBC |
triple-negative breast cancer |
Tregs |
regulatory T cells |
VEGF |
vascular endothelial growth factor |